Growth hormone deficiency classification: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Growth hormone deficiency}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==Reference...") |
Usama Talib (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Growth hormone deficiency}} | {{Growth hormone deficiency}} | ||
{{CMG}}; {{AE}} | |||
==Overview== | |||
*There is no established system for the classification of [disease name]. | |||
OR | |||
*[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4]. | |||
OR | |||
*[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. | |||
*[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3]. | |||
OR | |||
*Based on the duration of symptoms, [disease name] may be classified as either acute or chronic. | |||
OR | |||
*If the staging system involves specific and characteristic findings and features: | |||
*According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2]. | |||
OR | |||
*The staging of [malignancy name] is based on the [staging system]. | |||
OR | |||
*There is no established system for the staging of [malignancy name]. | |||
==Classification== | |||
*There is no established system for the classification of [disease name]. | |||
OR | |||
*[Disease name] may be classified according to [classification method] into [number] subtypes/groups: | |||
**[group1] | |||
**[group2] | |||
**[group3] | |||
**[group4] | |||
OR | |||
*[Disease name] may be classified into [large number > 6] subtypes based on: | |||
**[classification method 1] | |||
**[classification method 2] | |||
**[classification method 3] | |||
*[Disease name] may be classified into several subtypes based on: | |||
**[classification method 1] | |||
**[classification method 2] | |||
**[classification method 3] | |||
OR | |||
*Based on the duration of symptoms, [disease name] may be classified as either acute or chronic. | |||
OR | |||
*If the staging system involves specific and characteristic findings and features: | |||
*According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2]. | |||
OR | |||
*The staging of [malignancy name] is based on the [staging system]. | |||
OR | |||
*There is no established system for the staging of [malignancy name]. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 18:13, 7 August 2017
Growth hormone deficiency Microchapters |
Differentiating Growth hormone deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Growth hormone deficiency classification On the Web |
American Roentgen Ray Society Images of Growth hormone deficiency classification |
Risk calculators and risk factors for Growth hormone deficiency classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
- There is no established system for the classification of [disease name].
OR
- [Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
OR
- [Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
- [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
OR
- Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
- If the staging system involves specific and characteristic findings and features:
- According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
- The staging of [malignancy name] is based on the [staging system].
OR
- There is no established system for the staging of [malignancy name].
Classification
- There is no established system for the classification of [disease name].
OR
- [Disease name] may be classified according to [classification method] into [number] subtypes/groups:
- [group1]
- [group2]
- [group3]
- [group4]
OR
- [Disease name] may be classified into [large number > 6] subtypes based on:
- [classification method 1]
- [classification method 2]
- [classification method 3]
- [Disease name] may be classified into several subtypes based on:
- [classification method 1]
- [classification method 2]
- [classification method 3]
OR
- Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
- If the staging system involves specific and characteristic findings and features:
- According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
- The staging of [malignancy name] is based on the [staging system].
OR
- There is no established system for the staging of [malignancy name].